Search For "bharat biotech"
Updated : 1 month ago IST
New Delhi [India], May 12 (ANI): The Delhi government has been forced to shut down 100 vaccination sites over 17 schools that administered Bharat Biotech's COVAXIN vaccine due to a dearth of supply from the manufacturer, Delhi Deputy Chief Minister Manish Sisodia said on Wednesday.
New Delhi [India], May 12 (ANI): The Subject Expert Committee (SEC) has given a nod to Bharat Biotech's Covaxin for Phase 2 and 3 human clinical trials on children aged between two to eight years old, sources confirmed on Wednesday.
New Delhi [India], May 11 (ANI): Bharat Biotech on Tuesday informed that the firm has been supplying its COVID-19 vaccine Covaxin directly to 18 states since May 1.
Updated : 1 month, 2 weeks ago IST
Mumbai (Maharashtra) [India], May 1 (ANI): Maharashtra Deputy Chief Minister Ajit Pawar has said that the state had planned a big COVID-19 vaccination event for Saturday but has only received 3 lakh doses out of which 20,000 doses have been given to Pune district, adding that the state go
Bhopal (Madhya Pradesh) [India], April 30 (ANI): The vaccination drive against COVID-19 for people aged 18 to 45 will be not be beginning from May 1 in Madhya Pradesh as vaccines are not available, Chief Minister Shivraj Singh Chauhan informed on Thursday.
New Delhi [India], April 30 (ANI): Bharat Biotech on Thursday announced it will supply its COVID-19 vaccine--Covaxin to state governments at Rs 400 per dose.
Mumbai (Maharashtra) [India], April 28 (ANI): The Maharashtra government has written to COVID-19 vaccine manufacturers Serum Institute of India (SII) and Bharat Biotech about the state's vaccination requirements ahead of the next phase of the inoculation drive which starts on May 1.
Updated : 1 month, 3 weeks ago IST
Hyderabad (Telangana) [India], April 24 (ANI): Covaxin, the indigenous vaccine against COVID-19 will be available for state governments at Rs 600 per dose and private hospitals at Rs 1,200 per dose, Hyderabad-based Bharat Biotech announced on Saturday.
Hyderabad (Telangana) [India], April 21 (ANI): Covaxin, India's indigenous vaccine against COVID-19 demonstrated "overall interim clinical efficacy" of 78 per cent and 100 per cent efficacy against "severe COVID-19 disease" in Phase-III trials, informed Bharat Biotech and Indian Council of M
New Delhi [India], April 21 (ANI): Indigenously-developed Covid-19 vaccine Covaxin, made by Bharat Biotech, neutralises multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well, the Indian Council of Medical Research (ICMR) said on Wednesday.
New Delhi [India], April 20 (ANI): Finance Minister Nirmala Sitharaman has approved a total of Rs 4,567.50 crore as advance payment to Serum Institute of India (SII) and Bharat Biotech to ramp up vaccine production against coronavirus, sources told ANI.
Updated : 2 months ago IST
New Delhi [India], April 16 (ANI): The current production capacity of indigenously developed Covaxin vaccine will be doubled by May-June 2021 and then increased nearly 6-7 fold by July-August 2021, the government announced on Friday as the country is witnessing a record surge in COVID-19 inf